Insulin-like growth factor-binding protein-3, breast cancer risk, and different serum assays

被引：0
|
作者：
Renehan, A [1 ]
机构：
[1] Christie Hosp NHS Trust, Dept Surg, Manchester M20 4BX, Lancs, England
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2005年 / 14卷 / 07期
关键词：
D O I：
10.1158/1055-9965.EPI-05-0214
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1844 / 1844
页数：1
相关论文
共 50 条
  • [31] Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3
    Lalou, C
    Lassarre, C
    Binoux, M
    HORMONE RESEARCH, 1996, 45 (3-5) : 156 - 159
  • [32] Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness
    Ahasic, Amy M.
    Tejera, Paula
    Wei, Yongyue
    Su, Li
    Mantzoros, Christos S.
    Bajwa, Ednan K.
    Thompson, B. Taylor
    Christiani, David C.
    CRITICAL CARE MEDICINE, 2015, 43 (12) : 2651 - 2659
  • [33] Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3
    Heding, A
    Gill, R
    Ogawa, Y
    DeMeyts, P
    Shymko, RM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) : 13948 - 13952
  • [34] Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase - Effects on the insulin-like growth factor signaling pathway
    Ricort, JM
    Binoux, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) : 19448 - 19454
  • [35] Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis
    B Liu
    K-W Lee
    M Anzo
    B Zhang
    X Zi
    Y Tao
    L Shiry
    M Pollak
    S Lin
    P Cohen
    Oncogene, 2007, 26 : 1811 - 1819
  • [36] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma
    Sungshim Lani Park
    Veronica Wendy Setiawan
    Peter A. Kanetsky
    Zuo-Feng Zhang
    Lynne R. Wilkens
    Laurence N. Kolonel
    Loïc Le Marchand
    Cancer Causes & Control, 2011, 22 : 1267 - 1275
  • [37] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma
    Park, Sungshim Lani
    Setiawan, Veronica Wendy
    Kanetsky, Peter A.
    Zhang, Zuo-Feng
    Wilkens, Lynne R.
    Kolonel, Laurence N.
    Le Marchand, Loic
    CANCER CAUSES & CONTROL, 2011, 22 (09) : 1267 - 1275
  • [38] SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 AND PROTEIN-3 IN WOMEN WITH REGULAR MENSTRUAL CYCLES
    WANG, HS
    LEE, JD
    SOONG, YK
    FERTILITY AND STERILITY, 1995, 63 (06) : 1204 - 1209
  • [39] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 are not useful markers of prostate cancer
    Zancan, M.
    Dittadi, R.
    Scattoni, V.
    Fandella, A.
    Del Bianco, P.
    Gion, M.
    EJC SUPPLEMENTS, 2007, 5 (08): : 36 - 36
  • [40] Insulin-like growth factor-binding protein-3 is induced by tamoxifen and fulvestrant and modulates fulvestrant response in breast cancer cells
    Flynn, Keenan L.
    Zheng, Yan
    Sowers, Janel Y.
    Masangya, Nefretiri J. T.
    Houston, Kevin D.
    FRONTIERS IN ONCOLOGY, 2024, 14
12345